Analgesics (Pharmacies) - Central America

  • Central America
  • Revenue in the Analgesics market is projected to reach US$237.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.22%, resulting in a market volume of US$352.50m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.49 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Central America is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Central America have shown a growing preference for analgesics purchased from pharmacies. This preference can be attributed to several factors. Firstly, customers perceive pharmacies as reliable sources of healthcare products, including analgesics. They trust the expertise of pharmacists and value the convenience of being able to consult with them before making a purchase. Additionally, pharmacies often stock a wide range of analgesics, offering customers a greater choice in terms of brands and formulations. This variety allows customers to select the product that best suits their specific needs.

Trends in the market:
One major trend in the Analgesics (Pharmacies) market in Central America is the increasing demand for over-the-counter (OTC) analgesics. This trend is driven by the growing awareness and acceptance of self-medication among consumers. OTC analgesics are easily accessible in pharmacies without the need for a prescription, making them a convenient option for customers seeking relief from minor aches and pains. This trend is also influenced by the rising healthcare costs and the desire to avoid unnecessary doctor visits for minor ailments. Another trend in the market is the growing popularity of natural and herbal analgesics. Consumers in Central America are becoming more health-conscious and are seeking alternatives to conventional pharmaceutical products. They are increasingly drawn to analgesics that are derived from natural sources and have fewer side effects. This trend is also fueled by the perception that natural and herbal products are more sustainable and environmentally friendly.

Local special circumstances:
Central America is a region that is prone to natural disasters, such as hurricanes and earthquakes. These events often result in injuries and an increased need for pain relief. As a result, the demand for analgesics in Central America can be influenced by these local special circumstances. Pharmacies play a crucial role in providing essential healthcare products, including analgesics, to affected communities during such times.

Underlying macroeconomic factors:
The growing Analgesics (Pharmacies) market in Central America can also be attributed to underlying macroeconomic factors. The region has been experiencing steady economic growth, resulting in an expanding middle class with increased purchasing power. This has led to a higher demand for healthcare products, including analgesics. Additionally, improvements in healthcare infrastructure and access to healthcare services have contributed to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Central America is developing due to customer preferences for pharmacy purchases, trends such as the demand for OTC and natural analgesics, local special circumstances like natural disasters, and underlying macroeconomic factors such as economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)